Catherine A. Sohn

Insider Reports History

Entity
Individual
Location
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4, Ireland
Signature
/s/ Richard Eisenstadt, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine A. Sohn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jazz Pharmaceuticals plc Director Ordinary Shares 14.9K $1.77M $119.13 Aug 14, 2023 Direct
LANDEC CORP \CA\ Director Common Stock 54.1K $563K $10.42 Jun 4, 2022 Direct
Altimmune, Inc. Director Stock Options (option to buy) 26.1K Sep 28, 2023 Direct
Rubius Therapeutics, Inc. Director Stock Option (Right to Buy) 25K May 12, 2022 Direct
Axcella Health Inc. Director Stock Option (Right to Buy) 20K May 19, 2022 Direct
LANDEC CORP \CA\ Director Restricted Stock Unit 0 $7.00 Jun 4, 2022 Direct

Insider Reports Filed by Catherine A. Sohn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALT Altimmune, Inc. Sep 28, 2023 1 $0 4 Sep 29, 2023 Director
JAZZ Jazz Pharmaceuticals plc Aug 11, 2023 2 -$171K 4 Aug 15, 2023 Director
ALT Altimmune, Inc. Mar 23, 2023 1 $0 4 Mar 27, 2023 Director
ALT Altimmune, Inc. Mar 23, 2023 0 $0 3 Mar 27, 2023 Director
JAZZ Jazz Pharmaceuticals plc Aug 5, 2022 2 -$166K 4 Aug 9, 2022 Director
LFCR LANDEC CORP \CA\ Jun 4, 2022 2 $0 4 Jun 7, 2022 Director
LFCR LANDEC CORP \CA\ May 31, 2022 1 $0 4 Jun 2, 2022 Director
AXLA Axcella Health Inc. May 19, 2022 1 $0 4 May 23, 2022 Director
RUBY Rubius Therapeutics, Inc. May 12, 2022 1 $0 4 May 13, 2022 Director
JAZZ Jazz Pharmaceuticals plc Aug 6, 2021 1 -$193K 4 Aug 10, 2021 Director
JAZZ Jazz Pharmaceuticals plc Jul 29, 2021 1 $0 4 Aug 2, 2021 Director
LFCR LANDEC CORP \CA\ Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
LFCR LANDEC CORP \CA\ Jun 1, 2021 2 $0 4 Jun 3, 2021 Director
AXLA Axcella Health Inc. May 20, 2021 1 $0 4 May 24, 2021 Director
RUBY Rubius Therapeutics, Inc. May 12, 2021 1 $0 4 May 13, 2021 Director